Results 61 to 70 of about 151,263 (303)

Admissible multiarm stepped‐wedge cluster randomized trial designs [PDF]

open access: yesStatistics in Medicine, 2018
Numerous publications have now addressed the principles of designing, analyzing, and reporting the results of stepped‐wedge cluster randomized trials. In contrast, there is little research available pertaining to the design and analysis of multiarm stepped‐wedge cluster randomized trials, utilized to evaluate the effectiveness of multiple experimental ...
Michael J. Grayling   +2 more
openaire   +5 more sources

Prospecting the protein design landscape

open access: yesFEBS Letters, EarlyView.
This review outlines the current state of various protein design approaches. We discuss the current possibilities enabled by recently released tools, highlight future avenues to pursue in protein design, and underscore the crucial role of key databases and resources for successful protein design workflows.
Jakob R. Riccabona   +4 more
wiley   +1 more source

Introducing the new CONSORT extension for stepped-wedge cluster randomised trials

open access: yesTrials, 2019
The use of the stepped-wedge cluster randomised trial (SW-CRT) is on the increase, and although there are still relatively few SW-CRTs currently published its use is bound to show an increase in the near future.
Karla Hemming   +2 more
doaj   +1 more source

Graphical representation of the standard stepped wedge design intervention roll-out.

open access: yes, 2018
Graphical representation of the standard stepped wedge design intervention roll-out.
Alecia Nickless (6082961)   +4 more
core   +1 more source

The heterodimeric amino acid transporters (HAT) of the SLC7/SLC3 family: A structure−function relationships and relevance to human pathology

open access: yesFEBS Letters, EarlyView.
Heterodimeric amino acid transporters consist of SLC7 and SLC3 family proteins arranged in a conserved structural organization. They regulate nutrient transport across cell membranes, supporting essential cellular functions. These transporters also contribute to xenobiotic/drug uptake and distribution.
Mariafrancesca Scalise   +5 more
wiley   +1 more source

Delaying and withholding interventions: ethics and the stepped wedge trial [PDF]

open access: yesJournal of Medical Ethics, 2019
Ethics has been identified as a central reason for choosing the stepped wedge trial over other kinds of trial designs. The potential advantage of the stepped wedge design is that it provides all arms of the trial with the active intervention over the course of the study.
openaire   +2 more sources

Leucine‐rich glioma inactivated 1 (LGI1) is a ganglioside‐binding protein

open access: yesFEBS Letters, EarlyView.
Neuronal hyperexcitability associated with a decrease/absence of the extracellular protein LGI1 has been suggested to be primarily due to the downregulation of Kv1 channel expression. The molecular mechanisms underlying this decrease have not yet been elucidated.
Kévin Debreux   +7 more
wiley   +1 more source

Status in each step of a complete factorial stepped wedge design for 2 interventions, with 4 steps, by sequence.

open access: yes, 2023
Status in each step of a complete factorial stepped wedge design for 2 interventions, with 4 steps, by sequence.
Florence Mgawadere (6340115)   +1 more
core   +1 more source

A context‐dependent modulatory role for eIF6 in acquired resistance to vemurafenib in melanoma

open access: yesFEBS Letters, EarlyView.
Acquired resistance to vemurafenib upregulates the translation factor eIF6 in melanoma cells. Silencing eIF6 in resistant cells reduces proliferation and partially restores drug sensitivity, whereas its overexpression increases sensitivity across melanoma lines regardless of BRAF status, via modulation of mTOR, S6K, and MAPK signaling.
George Kyriakopoulos   +9 more
wiley   +1 more source

Prevalence and methodological characteristics of subgroup analyses in stepped wedge cluster randomised trials: A systematic review protocol

open access: yes, 2020
The stepped wedge cluster randomised trial is an increasingly common trial design. The design can be useful to inform real-world clinical decision-making, including decisions about the effectiveness of interventions in particular subgroups.
Pierre J Durand   +5 more
core   +3 more sources

Home - About - Disclaimer - Privacy